Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesRequired area of lymph node sampling during segmentectomy for clinical stage IA non-small cell lung cancer
The Journal of Thoracic and Cardiovascular Surgery, 06/19/09
Nomori H et al. – Data suggest that segmental lymph nodes should be dissected at both the resected and nonresected segments during segmentectomy, especially for tumors in the anteriorly located segment, because the lymphatic flow from the anteriorly located segment can frequently go directly to the segmental lymph nodes of the posteriorly located segment.
Methods- Aim was to investigate the required area of lymph node sampling during segmentectomy, especially for segmental nodes at the nonresected segments
- Distribution of sentinel nodes in pts with NSCLC who underwent segmentectomy were examined
- 94 pts with NSCLC were treated by using segmentectomy and dissection of lymph nodes
- Anatomic locations of the segments were classified as either anterior or posterior
- Correlations of anatomic location with the distribution of sentinel nodes at the segmental nodes were then examined
- Of the 94 pts, segmental nodes at both the resected and nonresected segments could be dissected in 42 pts
- Segmental sentinel nodes were found at the resected segments in 64% of pts
- This was significantly higher than that seen at the nonresected segments
- 47% of pts with tumors in the anteriorly located segments had segmental sentinel nodes at the nonresected segments
- This was higher than that seen in pts with tumors in the posteriorly located segments
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer
Journal of Clinical Oncology, 10/29/09
New Advances in the Second-Line Treatment of Small Cell Lung Cancer
The Oncologist, 10/28/09
Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer
Journal of Clinical Oncology, 11/05/09
Today in Surgery/Trauma...keeping you current
Receive free subspecialty "5-minute updates" via email
Pulmonary Embolism and Deep Venous Thrombosis in Trauma
Archives of Surgery, 10/20/09
Pneumonectomy After Neoadjuvant Chemotherapy and Radiation for Advanced-Stage Lung Cancer
Annals of Surgical Oncology, 11/18/09
Postoperative Pulmonary Complications after Laparotomy
Respiration, 10/28/09
Sponsor
Article Search
Sponsor